Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Tops Revenue Estimates
1/3 00:15
Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.16 per share a year ago. These figures are adjusted for non-recurring items....